Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension.

Robbins IM, Hemnes AR, Gibbs JS, Christman BW, Howard L, Meehan S, Cabrita I, Gonzalez R, Oyler T, Zhao L, Du RH, Mendes LA, Wilkins MR
Exp Lung Res. 2011 37 (1): 26-34

PMID: 21077779 · DOI:10.3109/01902148.2010.512972

MeSH Terms (30)

Administration, Oral Adult Antihypertensive Agents Biomarkers Biopterin Chemokine CCL2 Drug Therapy, Combination Endothelin Receptor Antagonists Exercise Test Exercise Tolerance Female Humans Hypertension, Pulmonary London Male Middle Aged Natriuretic Peptide, Brain Nitric Oxide Oxidative Stress Peptide Fragments Phosphodiesterase 5 Inhibitors Piperazines Purines Recovery of Function Sildenafil Citrate Sulfones Tennessee Time Factors Treatment Outcome Walking

Connections (2)

This publication is referenced by other Labnodes entities: